Towards Healthcare
Cytology Brushes Market Size Sees 7.36% CAGR in 2025

Cytology Brushes Market Expands in 2025 Amid Innovations in Liquid-Based Cytology and AI Integration

According to market projections, the cytology brushes sector is expected to grow from USD 1.68 billion in 2024 to USD 3.4 billion by 2034, reflecting a CAGR of 7.36%. The global market is propelled by growing cancer cases, including cervical cancer, respiratory cancer, and the adoption of minimally invasive procedures. However, North America led the market due to accelerating early disease detection and preventive healthcare practices, and the expansion of healthcare infrastructure.

Content

  • Insight Code: 5845
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The cytology brushes market is projected to reach USD 3.4 billion by 2034, growing at a CAGR of 7.36% from 2024 to 2034.

North America is currently leading the cytology brushes market due to rising prior disease detection and preventive healthcare practices, and the expansion of healthcare infrastructure.

The cytology brushes market includes 5 segments, such as by product type, by material, by application, by end user, and by region.

Some key players include Boston Scientific Corporation, Olympus Corporation, Cook Medical, ConMed Corporation, and U.S. Endoscopy.

Key trends include rising demand for user-friendly brushes, endoscopy procedures, growth in awareness about cervical cancer and early cancer screening, and innovation in brush design and minimally invasive procedures.

The potential risks associated with brush use are perforation, infection, bleeding, or allergic reactions.

Brush cytology is a sampling technique widely used for mucosal surfaces, especially to identify malignancies.

The future of cervical cancer screening involves personalized approaches, potentially using AI and machine learning to determine individuals at major risk and customize screening strategies. 

NIH.GOV, CDC.GOV, US FDA, WHO, NCI, CLINICALTRIALS.GOV, MEDLINEPLUS.GOV
Any Questions